SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:8810b55c-d0d9-467f-b719-70a640095629"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:8810b55c-d0d9-467f-b719-70a640095629" > Noncanonical immuno...

Noncanonical immunomodulatory activity of complement regulator C4BP(β-) limits the development of lupus nephritis

Luque, Ana (författare)
Bellvitge Biomedical Research Institute,L'Hospitalet de Llobregat, Barcelona
Serrano, Inmaculada (författare)
L'Hospitalet de Llobregat, Barcelona,Bellvitge Biomedical Research Institute
Ripoll, Elia (författare)
Bellvitge University Hospital-IDIBELL,University of Barcelona
visa fler...
Malta, Catarina (författare)
Bellvitge Biomedical Research Institute,L'Hospitalet de Llobregat, Barcelona
Gomà, Montserrat (författare)
Bellvitge University Hospital-IDIBELL
Blom, Anna M. (författare)
Lund University,Lunds universitet,Proteinkemi, Malmö,Forskargrupper vid Lunds universitet,Protein Chemistry, Malmö,Lund University Research Groups
Grinyó, Josep M. (författare)
University of Barcelona,Bellvitge University Hospital-IDIBELL
Rodríguez de Córdoba, Santiago (författare)
Biological Research Center (CIB), Madrid
Torras, Joan (författare)
University of Barcelona,Bellvitge University Hospital-IDIBELL
Aran, Josep M. (författare)
L'Hospitalet de Llobregat, Barcelona,Bellvitge Biomedical Research Institute
visa färre...
 (creator_code:org_t)
Elsevier BV, 2020
2020
Engelska 16 s.
Ingår i: Kidney International. - : Elsevier BV. - 0085-2538. ; 97:3, s. 551-566
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Lupus nephritis is a chronic autoimmune-inflammatory condition that can lead to end-stage kidney disease. Presently available immunosuppressive treatments for lupus nephritis are suboptimal and can induce significant side effects. Recently, we characterized a novel immunomodulatory activity of the minor isoform of the classical pathway complement inhibitor, C4BP(β-). We show here that C4BP(β-) treatment prevented the development of proteinuria and albuminuria, decreased significantly the formation of anti-dsDNA antibodies and, locally, mitigated renal glomerular IgG and C3 deposition and generation of apoptotic cells. There was a consequent histological improvement and increased survival in lupus-prone mice. The therapeutic efficacy of C4BP(β-) was analogous to that of the broad-acting immunosuppressant cyclophosphamide. Remarkably, a comparative transcriptional profiling analysis revealed that the kidney gene expression signature resulting from C4BP(β-) treatment turned out to be 10 times smaller than that induced by cyclophosphamide treatment. C4BP(β-) immunomodulation induced significant downregulation of transcripts relevant to lupus nephritis indicating immunopathogenic cell infiltration, including activated T cells (Lat), B cells (Cd19, Ms4a1, Tnfrsf13c), inflammatory phagocytes (Irf7) and neutrophils (Prtn3, S100a8, S100a9). Furthermore, cytokine profiling and immunohistochemistry confirmed that C4BP(β-), through systemic and local CXCL13 downregulation, was able to prevent ectopic lymphoid structures neogenesis in aged mice with lupus nephritis. Thus, due to its anti-inflammatory and immunomodulatory activities and high specificity, C4BP(β-) could be considered for further clinical development in patients with systemic lupus erythematosus.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)

Nyckelord

C4BP(β−)
dendritic cells
ectopic lymphoid structures
immunomodulation
inflammation
lupus nephritis

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy